IMX Data, a provider of comprehensive healthcare claims data for institutional clients, has obtained SOC 2 certification, confirming its robust controls for security, availability, and confidentiality.
SOC 2 certification is an independent, third-party attestation that verifies an organization’s adherence to the American Institute of Certified Public Accountants’ (AICPA) standards for managing customer data securely. This achievement highlights IMX Data’s dedication to safeguarding sensitive information and meeting the compliance requirements of its enterprise, institutional, and regulated clients.
Jim Plante, CEO of IMX Data, stated, “Achieving SOC 2 certification is a significant milestone for IMX Data and reflects our continued investment in building a secure, scalable, and trusted data platform. Our clients rely on us not only for the depth and timeliness of our healthcare data, but also for the integrity and security of the systems that support it.”
IMX Data collaborates with institutional investors and financial firms who necessitate strong governance and security standards in their vendor due diligence processes. The SOC 2 certification reinforces IMX Data’s capacity to confidently support these organizations.
The company’s platform serves as a healthcare analytics resource for institutional equities investors and systematic trading firms. It offers a comprehensive healthcare claims dataset, comprising over 85 billion medical and pharmaceutical transactions from more than 330 million anonymized patients. This infrastructure is designed to provide buy-side firms with granular, real-time data for constructing sophisticated trading models and generating alpha.
The platform includes longitudinal clinical records spanning from 2015 to the present, featuring over 400,000 ICD, CPT, HCPCS, and National Drug Codes. This enables multi-dimensional analysis across various therapeutic areas, treatment patterns, pharmaceutical adoption cycles, and healthcare provider networks. Buy-side teams leverage this data to identify emerging drug adoption trends, model prescription volume inflection points, analyze payor mix dynamics, and anticipate shifts in healthcare utilization patterns, which are crucial signals for healthcare equities trading. With millions of new claims added daily and minimal latency delivery, IMX Data offers near real-time visibility into the evolving healthcare landscape. Its SOC 2-certified infrastructure adheres to the security and governance standards demanded by institutional investors and supports seamless integration into existing trading platforms and analytical workflows, empowering quantitative researchers and portfolio managers to develop proprietary models.
